Mark T. Esser

14.5k citations
100 papers · 6.4k · 4 hit papers · h-index 43

Impact in

  • Epidemiology top 0.2%
    • Cervical Cancer and HPV Research
    • Hepatitis B Virus Studies
    • Respiratory viral infections research
    • Pneumonia and Respiratory Infections
  • Virology top 2%

Papers in

    • Respiratory viral infections research 35
    • Cervical Cancer and HPV Research 24
    • Pneumonia and Respiratory Infections 17
    • Hepatitis B Virus Studies 16
    • SARS-CoV-2 and COVID-19 Research 12
    • Viral gastroenteritis research and epidemiology 11

Mark T. Esser

98 papers receiving 6.2k citations

Mark T. Esser's Hit Papers

Durability of neutralizing RSV antibodies following nirsevimab administration and elicitation of the natural immune response to RSV infection in infants 2023 · 70 citations
700+6+12Years since publication4008001.2k

Peers

Mark T. Esser
Comparison fields: 5 of 121
  • Epidemiology 4.6k
  • Virology 356
  • Infectious Diseases 1.3k
  • Immunology 1.4k
  • Microbiology 397
Replace Kathrin U. Jansen with:
Kathrin U. Jansen United States
John F. Modlin United States
Joseph B. Domachowske United States
Amalia Magaret United States
Charles Lacey United Kingdom
Gary Dubin United States
Donna M. Ambrosino United States
Nancy B. Kiviat United States
Nancy B. Kiviat United States
Mark H. Einstein United States
Mark T. Esser relative to Kathrin U. Jansen United States Kathrin U. Jansen's profile →
Citations per field
00.5×1.5×
Kathrin U. Jansen · 1×
Citations per year

Countries citing papers authored by Mark T. Esser

Since Specialization
Citations

This map shows the geographic impact of Mark T. Esser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark T. Esser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark T. Esser more than expected).

Fields of papers citing papers by Mark T. Esser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark T. Esser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark T. Esser. The network helps show where Mark T. Esser may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark T. Esser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark T. Esser Line = papers co-authored together Mark T. Esser links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 100 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases
Hit paper breakdown →
20071353
2
Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants
Hit paper breakdown →
2020456
3 2009362
4 2003230
5 2007225
6 2005204
7 2018160
8 2003147
9 2001145
10 2010133
11
Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial
Hit paper breakdown →
2022127
12 2016113
13 2007108
14 2008104
15 2016104
16 2007102
17 201791
18 201290
19 200283
20 199582

About Mark T. Esser

Mark T. Esser is a scholar working on Epidemiology, Infectious Diseases, Immunology, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 100 papers that have together received 6.4k indexed citations. Recurring topics across this work include Respiratory viral infections research (35 papers), Cervical Cancer and HPV Research (24 papers), Pneumonia and Respiratory Infections (17 papers), Hepatitis B Virus Studies (16 papers), Immunotherapy and Immune Responses (13 papers), SARS-CoV-2 and COVID-19 Research (12 papers), Immune Cell Function and Interaction (11 papers) and Viral gastroenteritis research and epidemiology (11 papers). The work is most often cited by research in Epidemiology (4.6k citations), Virology (356 citations), Infectious Diseases (1.3k citations), Immunology (1.4k citations) and Microbiology (397 citations). Mark T. Esser has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Eliav Barr, Janine T. Bryan, Tonya Villafana, Filip Dubovsky, Frank J. Taddeo, Heather L. Sings, Therese Takas, Carlos Sattler, M. Pamela Griffin and Narendra Chirmule. Their work appears in journals such as Clinical and Vaccine Immunology, The Journal of Infectious Diseases, Open Forum Infectious Diseases, PLoS ONE and Clinical & Translational Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact